Antiretroviral treatment of central nervous system HIV-1 infection: a review.
about
Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virusCNS activity of Pokeweed anti-viral protein (PAP) in mice infected with lymphocytic choriomeningitis virus (LCMV)Progressive increase in central nervous system immune activation in untreated primary HIV-1 infectionCross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course.Practical aspects of transporter model systems: a case study involving SQV.Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.A family history of psychopathology modifies the decrement in cognitive control among patients with HIV/AIDS.Suppression of HIV-1 Infectivity by Human Glioma Cells.Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children.No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations.Efavirenz pharmacokinetics in cerebrospinal fluid and plasma over a 24-hour dosing interval.Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and post-mortem.[Neurological findings in a group of children and adolescents exposed and infected by HIV-1].Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).
P2860
Q24794317-0FC25B56-D466-479A-B853-1135BAAC8012Q24800765-57A69158-CD71-432E-9C9E-36E714EFDB9DQ34678105-B00686D8-32C4-4DFC-980A-BB531F5D56FDQ34950897-FEE71368-74DA-428C-B2F8-6490FC9B6FA0Q35828049-05224CB0-CC95-4FBE-BFB6-32C71FD1E099Q36583732-2CB9E889-50FF-47F2-911C-46692F927610Q36742751-7FBB3BF5-4D0E-462D-81A4-DDAB79CDB0A4Q38813153-06CC4305-84E8-4DD8-94BA-8459F87A9D45Q38851296-0597459F-AB3D-496B-8905-B4BBEA822684Q39191315-A4B9ABE9-CFEE-4B98-A1FF-9525B3DD6BA2Q42281323-651F30FA-E336-4BF4-8AFC-5FA686DC61B8Q44740845-85A652D7-73B1-47AB-8542-511488FF66CEQ46782330-0A97D826-8849-445C-81CC-F14925EF067BQ46812278-47D59F3D-FAF2-4770-AD1D-6F52E0A597C5Q48415542-7E115108-2510-4B6E-8CA0-DDB4B24288A7
P2860
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@ast
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@en
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@nl
type
label
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@ast
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@en
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@nl
prefLabel
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@ast
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@en
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@nl
P2860
P1433
P1476
Antiretroviral treatment of central nervous system HIV-1 infection: a review.
@en
P2093
P2860
P304
P356
10.1046/J.1468-1293.2001.00056.X
P577
2001-04-01T00:00:00Z